Torrent Pharma gets a nod from USFDA

Published On 2016-03-19 06:03 GMT   |   Update On 2016-03-19 06:03 GMT
New Delhi : Drug firm Torrent Pharma said its third manufacturing plant in Gujarat has obtained the Establishment Inspection Report (EIR) from the US health regulator US Food and Drug Administration (USFDA).

"Torrent Pharma has successfully obtained the Establishment Inspection Report from the USFDA for its plant located at Dahej SEZ, in Gujarat the plant has also received approval from EU Germany," Torrent Pharma said in a BSE filing.

It further said: "It was set up to cater mainly to the regulated international markets such as the US, Brazil, Germany etc."

With the approval, this plant is now the third plant of Torrent Pharma to receive USFDA approval, out of its 5 manufacturing plants.

"The company's other FDA approved plants include the plant at Indrad, Gujarat and Pithampur (Indore), MP," it added.

Shares of Torrent Pharma were trading at Rs 1,293.25, up 2.93 per cent, from the previous close on BSE.

 
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News